On the irreversible inhibition of alpha-chymotrypsin, trypsin, pancreatic kallikrein, thrombin and elastase by N-(beta-pyridylmethyl)-3,4-dichlorophenoxyacetamide-p-fluorosulfonylacetanilide bromide.
D000081:Acetamides / Q000494:pharmacology; D000083:Acetanilides / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D002417:Cattle; D002918:Chymotrypsin / Q000037:antagonists & inhibitors*; D007211:Indoles / Q000494:pharmacology; D007610:Kallikreins / Q000037:antagonists & inhibitors*; D007700:Kinetics; D008433:Mathematics; D010179:Pancreas / Q000187:drug effects / Q000201:enzymology*; D010196:Pancreatic Elastase / Q000037:antagonists & inhibitors*; D011485:Protein Binding; D011725:Pyridines / Q000494:pharmacology; D011773:Pyruvates / Q000494:pharmacology; D013450:Sulfones / Q000494:pharmacology*; D013552:Swine; D013917:Thrombin / Q000037:antagonists & inhibitors*; D014361:Trypsin Inhibitors / Q000032:analysis*
D000081:Acetamides; D000083:Acetanilides; D007211:Indoles; D011725:Pyridines; D011773:Pyruvates; D013450:Sulfones; D014361:Trypsin Inhibitors; D007610:Kallikreins; D002918:Chymotrypsin; D010196:Pancreatic Elastase; D013917:Thrombin